Double-Drug attack before surgery aims to wipe out esophageal cancer
NCT ID NCT07191977
Summary
This study is testing whether giving two cancer drugs together before surgery is safe and effective for people with a type of esophageal cancer that can be removed. One drug boosts the immune system to fight cancer, and the other blocks cancer cell growth. The main goal is to see if this combination can shrink tumors significantly before the operation, potentially leading to better long-term results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUR CELL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.